Advertisement

Amino Acids

, Volume 35, Issue 2, pp 339–343 | Cite as

Protein expression of BACE1, BACE2 and APP in Down syndrome brains

  • M. S. Cheon
  • M. Dierssen
  • S. H. Kim
  • G. Lubec
Article

Summary.

Down syndrome (DS) is the most common human chromosomal abnormality caused by an extra copy of chromosome 21. The phenotype of DS is thought to result from overexpression of a gene or genes located on the triplicated chromosome or chromosome region. Several reports have shown that the neuropathology of DS comprises developmental abnormalities and Alzheimer-like lesions such as senile plaques. A key component of senile plaques is amyloid β-peptide which is generated from the amyloid precursor protein (APP) by sequential action of β-secretases (BACE1 and BACE2) and γ-secretase. While BACE1 maps to chromosome 11, APP and BACE2 are located on chromosome 21. To challenge the gene dosage effect and gain insight into the expressional relation between β-secretases and APP in DS brain, we evaluated protein expression levels of BACE1, BACE2 and APP in fetal and adult DS brain compared to controls. In fetal brain, protein expression levels of BACE2 and APP were comparable between DS and controls. BACE1 was increased, but did not reach statistical significance. In adult brain, BACE1 and BACE2 were comparable between DS and controls, but APP was significantly increased. We conclude that APP overexpression seems to be absent during the development of DS brain up to 18–19 weeks of gestational age. However, its overexpression in adult DS brain could lead to disturbance of normal function of APP contributing to neurodegeneration. Comparable expression of BACE1 and BACE2 speaks against the hypothesis that increased β-secretase results in (or even underlies) increased production of amyloidogenic Aβ fragments.

Furthermore, current data indicate that the DS phenotype cannot be fully explained by simple gene dosage effect.

Keywords: Amyloid precursor protein – β-site APP-cleaving enzyme – Down syndrome – Protein expression 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acquati, F, Accarino, M, Nucci, C, Fumagalli, P, Jovine, L, Ottolenghi, S, Taramelli, R 2000The gene encodin DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the Down critical regionFEBS Lett4685964PubMedCrossRefGoogle Scholar
  2. Arai, Y, Suzuki, A, Mizuguchi, M, Takashima, S 1997Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brainsBrain Dev19290294PubMedCrossRefGoogle Scholar
  3. Barbiero, L, Benussi, L, Ghidoni, R, Alberici, A, Russo, C, Schettini, G, Parati, EA, Mazzoli, F, Nicosia, F, Signorini, S, Feudatari, E, Binetti, G 2003BACE-2 is overexpressed in Down’s syndromeExp Neurol182335345PubMedCrossRefGoogle Scholar
  4. Bigl, M, Apelt, J, Luschekina, EA, Lange-Dohna, C, Rossner, S, Schliebs, R 2000Expression of beta-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathologyNeurosci Lett292107110PubMedCrossRefGoogle Scholar
  5. Cai, H, Wang, Y, McCarthy, D, Wen, H, Borchelt, DR, Price, DL, Wong, PC 2001BACE1 is the major beta-secretase for generation of Abeta peptides by neuronsNat Neurosci4233234PubMedCrossRefGoogle Scholar
  6. Cheon, MS, Kim, SH, Yaspo, ML, Blasi, F, Aoki, Y, Melen, K, Lubec, G 2003aProtein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I)Amino Acids24111117Google Scholar
  7. Cheon, MS, Bajo, M, Kim, SH, Claudio, JO, Stewart, AK, Patterson, D, Kruger, WD, Kondoh, H, Lubec, G 2003bProtein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II)Amino Acids24119125Google Scholar
  8. Cheon, MS, Kim, SH, Ovod, V, Kopitar Jerala, N, Morgan, JI, Hatefi, Y, Ijuin, T, Takenawa, T, Lubec, G 2003cProtein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III)Amino Acids24127134Google Scholar
  9. Cheon, MS, Shim, KS, Kim, SH, Hara, A, Lubec, G 2003dProtein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part IV)Amino Acids254147Google Scholar
  10. Engidawork, E, Lubec, G 2001Protein expression in Down syndrome brainAmino Acids21331361PubMedCrossRefGoogle Scholar
  11. Epstein, CJ 1995Down syndromeScriver, CRBeaudet, ALSly, WSValle, D eds. The metabolic and molecular bases of inherited diseaseMcGraw HillNew York749794Google Scholar
  12. Farzan, M, Schnitzler, CE, Vasilieva, N, Leung, D, Choe, H 2000BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor proteinProc Natl Acad Sci USA9797129717PubMedCrossRefGoogle Scholar
  13. Ferrando-Miguel, R, Cheon, MS, Lubec, G 2004Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain (Part V): overexpression of phosphatidyl-inositol-glycan class P protein (DSCR5)Amino Acids26255261PubMedCrossRefGoogle Scholar
  14. Fluhrer, R, Capell, A, Westmeyer, G, Willem, M, Hartung, B, Condon, MM, Teplow, DB, Haass, C, Walter, J 2002A non-amyloidogenic function of BACE-2 in the secretory pathwayJ Neurochem8110111020PubMedCrossRefGoogle Scholar
  15. Griffin, WST, Sheng, JG, McKenzie, LE, Royston, MC, Gentleman, SM, Brumback, RA, Cork, LC, Del Bigio, MR, Roberts, GW, Mrak, RE 1998Lifelong expression of S-100β in Down’s syndrome: implication for Alzheimer pathogenesisNeurobiol Aging19401405PubMedCrossRefGoogle Scholar
  16. Gulesserian, T, Engidawork, E, Fountoulakis, M, Lubec, G 2007Manifold decrease of sialic acid synthase in fetal Down syndrome brainAmino Acids32141144PubMedCrossRefGoogle Scholar
  17. Holsinger, RMD, McLean, CA, Beyreuther, K, Masters, CL, Evin, G 2002Increased expression of amyloid precursor β-secretase in Alzheimer’s diseaseAnn Neurol51783786PubMedCrossRefGoogle Scholar
  18. Hussain, I, Powell, D, Howlett, DR, Tew, DG, Meek, TD, Chapman, C, Gloger, IS, Murphy, KE, Southan, CD, Ryan, DM, Smith, TS, Simmons, DL, Walsh, FS, Dingwall, C, Christie, G 1999Identification of a novel aspartic protease (Asp2) as betasecretaseMol Cell Neuosci14419427CrossRefGoogle Scholar
  19. Hussain, I, Powell, DJ, Howlett, DR, Chapman, GA, Gilmour, L, Murdock, PR, Tew, DG, Meek, TD, Chapman, C, Schneider, K, Ratcliffe, SJ, Tattersall, D, Testa, TT, Southan, C, Ryan, DM, Simmons, DL, Walsh, FS, Dingwall, C, Christie, G 2000Asp1 (BACE2) cleaves the amyloid precursor protein at the β-secretase siteMol Cell Neurosci16609619PubMedCrossRefGoogle Scholar
  20. Lin, X, Koelsch, G, Wu, S, Downs, D, Dashti, A, Tang, J 2000Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor proteinProc Natl Acad Sci USA9714561460PubMedCrossRefGoogle Scholar
  21. Marcinkiewicz, M, Seidah, NG 2000Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brainJ Neurochem7521332143PubMedCrossRefGoogle Scholar
  22. Mattson, MP, Cheng, B, Culwell, AR, Esch, FS, Lieberburg, I, Rydel, RE 1993Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor proteinNeuron10243254PubMedCrossRefGoogle Scholar
  23. Neve, RL, McPhie, DL, Chen, MY 2000Alzheimer’s disease: a dysfunction of amyloid precursor proteinBrain Res8865466PubMedCrossRefGoogle Scholar
  24. Rossner, S, Apelt, J, Schiebs, R, Perez-Polo, JR, Bigl, V 2001Neuronal and glial beta-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathologyJ Neurosci Res64437446PubMedCrossRefGoogle Scholar
  25. Rossner, S, Ueberham, U, Schliebs, R, Perez-Polo, JR, Bigl, V 1998The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signalingProgr Neurobiol56541569CrossRefGoogle Scholar
  26. Saunders, AJ, Kim, TW, Tanzi, RE 1999BACE maps to chromosome 11 and BACE homolog, BACE2, reside in the obligate Down syndrome region of chromosome 21Science2861255aCrossRefGoogle Scholar
  27. Schmidt-Sidor, B, Wisniewski, KE, Shepard, TH, Sersen, EA 1990Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 monthsClin Neuropathol9181190PubMedGoogle Scholar
  28. Shin, JH, Krapfenbauer, K, Lubec, G 2006Mass-spectrometrical analysis of proteins encoded on chromosome 21 in human fetal brainAmino Acids31435447PubMedCrossRefGoogle Scholar
  29. Sinha, S, Anderson, JP, Barbour, R, Basi, GS, Caccavello, R, Davis, D, Doan, M, Dovey, HF, Frigon, N, Hong, J, Jacobson-Croak, K, Jewett, N, Keim, P, Knops, J, Lieberburg, I, Power, M, Tan, H, Tatsuno, G, Tung, J, Schenk, D, Seubert, P, Suomensaari, SM, Wang, S, Walker, D, John, V 1999Purification and cloning of amyloid precursor protein beta-secretase from human brainsNature402537540PubMedCrossRefGoogle Scholar
  30. Takashima, S, Becker, LE, Armstrong, D, Chan, F 1981Abnormal neuronal development in the visual cortex of the human fetus and infant with Down’s syndrome. A quantitative and qualitative Golgi studyBrain Res225121PubMedCrossRefGoogle Scholar
  31. Takashima, S, Kuruta, H, Mito, T, Nishizawa, M, Kunishita, T, Tabira, T 1990Developmental and aging changes in the expression patterns of beta-amyloid in the brains of normal and Down syndrome casesBrain Dev1223672371Google Scholar
  32. Teller, JK, Russo, C, DeBusk, LM, Angelini, G, Zaccheo, D, Dagna-Bricarelli, F, Scartezzini, P, Bertolini, S, Mann, DMA, Tabaton, M, Gambetti, P 1996Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down’s syndromeNature Med29395PubMedCrossRefGoogle Scholar
  33. Vassar, R, Bennett, BD, Babu-Khan, S, Kahn, S, Mendiaz, EA, Denis, P, Teplow, DB, Ross, S, Amarante, P, Loeloff, R, Luo, Y, Fisher, S, Fuller, J, Edenson, S, Lile, J, Jarosinski, MA, Biere, AL, Curran, E, Burgess, T, Louis, JC, Collins, F, Treanor, J, Rogers, G, Citron, M 1999β-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACEScience286735741PubMedCrossRefGoogle Scholar
  34. Wallace, W, Akar, CA, Lyons, WE 1997Amyloid precursor protein potentiates the neurotrophic activity of NGFMol Brain Res52201212PubMedCrossRefGoogle Scholar
  35. Wasco, W, Tanzi, RE 1995Molecular genetics of amyloid and apolipoprotein E in Alzheimer’s diseaseDawbarn, DAllen, SJ eds. Neurobiology of Alzheimer’s diseaseBIOS Scientific PublishersOxford5176Google Scholar
  36. Wisniewski, KE, Kida, E 1994Abnormal neurogenesis and synaptogenesis in Down syndrome brainDev Brain Dysfunct7289301Google Scholar
  37. Wisniewski, KE, Wisniewski, HM, Wen, GY 1985Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down syndromeAnn Neurol17278282PubMedCrossRefGoogle Scholar
  38. Yan, R, Bienkowski, MJ, Shuck, ME, Miao, H, Tory, MC, Pauley, AM, Brashier, JR, Stratman, NC, Mathews, WR, Buhl, AE, Carter, DB, Tomasselli, AG, Parodi, LA, Heinrikson, RL, Gurney, ME 1999Membrane-anchored aspartyl protease with Alzheimer’s disease beta-secretase activityNature402533537PubMedCrossRefGoogle Scholar
  39. Yasojima, K, McGeer, EG, McGeer, PL 2001Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brainBrain Res919115121PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • M. S. Cheon
    • 1
    • 2
  • M. Dierssen
    • 3
  • S. H. Kim
    • 1
    • 4
  • G. Lubec
    • 1
  1. 1.Department of PediatricsMedical University of ViennaViennaAustria
  2. 2.Department of Herbal Resources ResearchKorea Institute of Oriental MedicineKorea
  3. 3.Genes and Disease ProgramGenomic Regulation Center-CRGBarcelonaSpain
  4. 4.Laboratory of Chemical GenomicsKorea Research Institute of Chemical TechnologyKorea

Personalised recommendations